Co-prescribing naloxone is recommended for your patients who are taking opioids and:7,8
- At a high strength (e.g., ≥ 50MME/day)* or as a long-term therapy
- With a benzodiazepine
- Have certain respiratory conditions, like COPD or sleep apnea
- Have a mental health disorder
- Have a history of overdose or substance use disorder, including PWUD and patients in recovery
- Are likely to observe an overdose among family, friends, or caregivers
Download the Kloxxado™ Co-RX Guide for more details.
* Your state PDMP may have built-in tools to help you assess a patient’s MME-associated risks.